Diabetic Ketoacidosis
8 drugs9,501 FAERS reportsMedDRA PT
GET
/api/v1/reaction/diabetic-ketoacidosisReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D016883
A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
Source: U.S. National Library of Medicine — MeSH (Diabetic Ketoacidosis)
Drugs reporting Diabetic Ketoacidosis (8)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Canagliflozin3,50811%
- 2Tubocurarine110%
- 3Nalmefene37.7%
- 4Empagliflozin4,1456.0%
- 5Inavolisib205.0%
- 6Ertugliflozin594.7%
- 7Capivasertib753.2%
- 8Dapagliflozin1,6903.0%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Ketoacidosis2 shared · 0.25
- Bipolar I Disorder2 shared · 0.22
- Fungal Infection4 shared · 0.20
- Blood Glucose Abnormal2 shared · 0.18
- Blood Glucose Increased6 shared · 0.09
- Hyperglycaemia2 shared · 0.09
- Drug Dependence2 shared · 0.05
- Dehydration5 shared · 0.04
- Urinary Tract Infection5 shared · 0.04
- Myocardial Infarction2 shared · 0.04
Literature
Recent PubMed references pinned to Diabetic Ketoacidosis as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission.Medical sciences (Basel, Switzerland) · 2026 · Sieben NA, Blank S, Tabah A, et al.PMID 42201041DOI 10.3390/medsci14020249
- Growth Hormone-Mediated Diabetic Ketoacidosis: A Rare Presentation of Acromegaly.Acta medica (Hradec Kralove) · 2026 · Polamuang W, Angsuwatcharakorn T, Santisukwongchote S, et al.PMID 42186927DOI 10.14712/18059694.2026.14
- 25-hydroxyvitamin D and the initial presentation of pediatric type 1 diabetes: associations with ketoacidosis severity and beta-cell function.Frontiers in endocrinology · 2026 · Ilmer S, Sohail R, Hyman S, et al.PMID 42169725DOI 10.3389/fendo.2026.1814563
- [Treatment of acute diabetic metabolic crises in adults (Update 2026)].Wiener klinische Wochenschrift · 2026 · Resl M, Kaser S, Sourij H, et al.PMID 42162479DOI 10.1007/s00508-025-02694-5
- A Systematic Review and Expert Evaluation of Perioperative SGLT2 Inhibitor-Associated Ketoacidosis Case Reports.Acta anaesthesiologica Scandinavica · 2026 · Snel LIP, Li X, Jamaludin F, et al.PMID 42130079DOI 10.1111/aas.70254
- A 48-Year-Old Man With Diabetic Ketoacidosis, Hypothermia, and Cardiac Arrest Managed With Veno-Arterial Extracorporeal Membrane Oxygenation.The American journal of case reports · 2026 · Masuda H, Shimono K, Banfuku A, et al.PMID 42124340DOI 10.12659/AJCR.952404
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.